Evidence map›Paper›PMID 25328027›Full record

ArticleBMC complementary and alternative medicine2014

In vitro anticoagulant and antioxidant activities of Jatropha gossypiifolia L. (Euphorbiaceae) leaves aiming therapeutical applications.

Juliana Félix-Silva, Thiago Souza, Rafael Barros Gomes Camara, Bárbara Cabral, Arnóbio Antônio Silva-Júnior, Ivanise Marina Moretti Rebecchi, Silvana Maria Zucolotto, Hugo Alexandre Oliveira Rocha, Matheus de Freitas Fernandes-Pedrosa

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Journal of experimental pharmacology · 2022
    Article
  4. TanP: A Multifunctional Anionic Peptide FromFrontiers in molecular biosciences · 2021
    Article
  5. Article
  6. Article
  7. Phytochemicals in Ischemic Stroke.Neuromolecular medicine · 2016
    Review
  8. Aqueous Leaf Extract ofBioMed research international · 2016
    Article
  9. A Review on Medicinal Properties of Orientin.Advances in pharmacological sciences · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Juliana Félix-Silva
Thiago Souza
Rafael Barros Gomes Camara
Bárbara Cabral
Arnóbio Antônio Silva-Júnior
Ivanise Marina Moretti Rebecchi
Silvana Maria Zucolotto
Hugo Alexandre Oliveira Rocha
Matheus de Freitas Fernandes-PedrosaLaboratório de Tecnologia & Biotecnologia Farmacêutica (TecBioFar), Departamento de Farmácia, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Rua Gal, Gustavo Cordeiro de Farias, s/n, Petrópolis, CEP 59012-570 Natal, RN, Brazil. mpedrosa@ufrnet.br.
Universidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJatropha gossypiifolia L. (Euphorbiaceae) is a medicinal plant largely used in folk medicine. Teas from the leaves are popularly used as an antithrombotic agent and the branches are frequently employed as a "thick blood" agent. Considering that the anticoagulant activity associated with antioxidant properties could be beneficial for various cardiovascular diseases, this study's aim is the evaluation of anticoagulant and antioxidant activities of J. gossypiifolia leaves, seeking new therapeutic purposes for this plant.

methodsThe aqueous leaf crude extract (CE) was prepared by decoction and was fractionated by liquid-liquid partition with solvents of increasing polarity. The phytochemical analysis was performed by thin layer chromatography (TLC) and by the spectrophotometric quantification of sugars, proteins and phenolic compounds. The anticoagulant activity was evaluated by prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests. The capacity to act in the fibrinolytic system (fibrinolytic and fibrinogenolytic activities) was also assessed. The antioxidant activity was evaluated by total antioxidant capacity, reducing power, copper chelating activity, iron chelating activity, hydroxyl radical scavenging activity and superoxide radical scavenging assays. The potential toxicity was evaluated using hemolytic assay and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay on HEK-293 cells.

resultsCE showed significant anticoagulant activity in aPTT test, while no action was observed in PT test, suggesting a preferential action toward the intrinsic and/or common pathway of coagulation. No effect was observed in the fibrinolytic system. Using the aPTT test, it was observed that the residual aqueous (RA) fraction was the most active, being two times more active than CE. RA presented very significant antioxidant activity in all models tested comparable to or even higher than CE. Regarding the safety, CE and RA did not produce significant cytotoxicity in both tests employed. Phytochemical analysis revealed the presence of alkaloids, flavonoids, proteins, tannins, steroids and/or terpenoids and sugars.

conclusionsCE and RA possessed significant anticoagulant and antioxidant activity and absence of cytotoxic effect in vitro, thus showing the potential of the plant, especially RA fraction, as a new source of bioactive molecules for therapeutic purposes, with particular emphasis on the treatment of cardiovascular diseases.

Indexed as

AnticoagulantsAntioxidantsErythrocytesFlavonoidsHEK293 CellsHumansJatrophaMedicine, TraditionalPlant ExtractsPlant LeavesPlants, MedicinalProthrombin TimeAnticoagulantsAntioxidantsFlavonoidsPlant Extracts

Identifiers

PMID25328027
PMCPMC4210492
OpenAlexW1976860896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.